PCV85 COST CONSEQUENCES OF REDUCED CVD RISK THROUGH IMPROVED SBP CONTROL- A COMPARATIVE ANALYSIS OF VALSARTAN VERSUS LOSARTAN
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74612-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)74612-X/fulltext
Title :
PCV85 COST CONSEQUENCES OF REDUCED CVD RISK THROUGH IMPROVED SBP CONTROL- A COMPARATIVE ANALYSIS OF VALSARTAN VERSUS LOSARTAN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74612-X&doi=10.1016/S1098-3015(10)74612-X
First page :
Section Title :
Open access? :
No
Section Order :
538